SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-058009
Filing Date
2022-05-10
Accepted
2022-05-10 09:18:51
Documents
14
Period of Report
2022-05-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2215025d1_8k.htm   iXBRL 8-K 30175
2 EXHIBIT 99.1 tm2215025d1_ex99-1.htm EX-99.1 12163
6 GRAPHIC tm2215025d1_ex99-1img01.jpg GRAPHIC 19277
  Complete submission text file 0001104659-22-058009.txt   249380

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA syn-20220510.xsd EX-101.SCH 3060
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20220510_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20220510_pre.xml EX-101.PRE 22614
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2215025d1_8k_htm.xml XML 3615
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 22907633
SIC: 2834 Pharmaceutical Preparations